Skip to main content
. 2023 May 31;34(8):1421–1432. doi: 10.1681/ASN.0000000000000171

Table 1.

Demographics and clinical characteristics of each cohort

Clinical Characteristic Kidney Donors (n=3020) Patients with Kidney Tumor (n=1363) Patients with Kidney Disease (N=314)
Mean (SD), Median (IQR), or n (%)
Demographic
 Age, yr 44.1 (12.1) 64.0 (11.9) 53.4 (18.0)
 Men, % 1235 (40.9) 873 (64.0) 167 (53.2)
 Race
  White or unknown 2772 (91.8) 1306 (95.8) 289 (92.1)
  Black 92 (3.0) 22 (1.6) 11 (3.5)
  American Indian/Alaskan Native 48 (1.6) 15 (1.1) 1 (0.3)
  Asian 43 (1.4) 4 (0.3) 13 (4.1)
  Other 65 (2.2) 16 (1.2) 0 (0.0)
CKD risk factors at baseline
 BMI, kg/m2 27.5 (4.8) 30.8 (6.7) 29.2 (6.9)
 Diabetes mellitus, % 0 (0) 185 (13.6) 73 (23.2)
 Hypertension, % 437 (14.5) 919 (67.4) 206 (65.6)
Kidney function at baseline
 Measured GFR, ml/min per 1.73 m2 104.1 (19.7)
 eGFR, ml/min per 1.73 m2 100.0 (16.2) 51.1 (13.8) 62.7 (31.8)
 24-h urine protein, mga 63 (52–94) 154 (87–307) 1913 (583–4372)
Kidney biopsy findings at baseline
 Total no. of glomeruli on biopsy 20.4 (11.1) 337.3 (155.5) 11.0 (8.9)
 Nephron size
  Glomerular tuft volume, mm3 0.0026 (0.0011) 0.0028 (0.0010) 0.0042 (0.0029)
  Nonsclerosed cortex per glomerulus, mm3 0.057 (0.028) 0.071 (0.028) 0.110 (0.113)
 Nephrosclerosis
  Globally sclerosed glomeruli, % 2.9 (5.3) 8.6 (8.7) 21.1 (22.9)
  IFTA, % 0.3 (1.2) 3.6 (7.5) 15.3 (17.7)
  IFTA density, foci per cm2 cortex 4.4 (11.8) 25.1 (20.9) 79.1 (77.2)
  Luminal stenosis (arteriosclerosis), %b 35.1 (17.6) 54.5 (15.5) 43.5 (18.3)
Progressive CKD outcome
 Kidney failure or 40% decline in eGFR 126 (9.2) 171 (54.5)

BMI, body mass index; IFTA, interstitial fibrosis and tubular atrophy.

a

Twenty-four–hour urine protein missing in 42 donors, 178 patients with tumor, and four native biopsy patients.

b

Missing in 80 donors because of lack of an artery.